2021
Mu, S., Palmer, D., Fitzgerald, R., Andreu-Vieyra, C., Zhang, H., Tang, Z., . . . Sahasranaman, S. (2021). Human Mass Balance and Metabolite Profiling of [<SUP>14</SUP>C]-Pamiparib, a Poly (ADP-Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 10(9), 1108-1120. doi:10.1002/cpdd.943DOI: 10.1002/cpdd.943
2017
Extracellular histones inhibit complement activation through interactions with complement component C4b (Conference Paper)
Qaddoori, Y., Abrams, S. T., Su, D., Liu, T., Alhamdi, Y., Wang, G., & Toh, C. -H. (2017). Extracellular histones inhibit complement activation through interactions with complement component C4b. In MOLECULAR IMMUNOLOGY Vol. 89 (pp. 132). doi:10.1016/j.molimm.2017.06.067DOI: 10.1016/j.molimm.2017.06.067
2016
Alhamdi, Y., Zi, M., Abrams, S., Liu, T., Su, D., Welters, I., . . . Toh, C. -H. (2016). Circulating Histone Concentrations Differentially Affect the Predominance of Left or Right Ventricular Dysfunction in Critical Illness. Critical Care Medicine, 44(05), e278-e288. doi:10.1097/CCM.0000000000001413DOI: 10.1097/CCM.0000000000001413
EXTRACELLULAR HISTONES ENHANCE FACTOR XA MEDIATED PROTHROMBIN ACTIVATION WITHOUT PHOSPHOLIPID REQUIREMENT (Conference Paper)
Sahraoui, Y., Abrams, S., Su, D., Alhamdi, Y., Foley, J., Wang, G., & Toh, C. H. (2016). EXTRACELLULAR HISTONES ENHANCE FACTOR XA MEDIATED PROTHROMBIN ACTIVATION WITHOUT PHOSPHOLIPID REQUIREMENT. In HAEMATOLOGICA Vol. 101 (pp. 310). Retrieved from https://www.webofscience.com/
Extracellular histones promote prothrombin activation in the absence of phospholipids (Conference Paper)
Sahraoui, Y., Abrams, S. T., Su, D., Alhamdi, Y., Foley, J., Wang, G., & Toh, C. H. (2016). Extracellular histones promote prothrombin activation in the absence of phospholipids. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 173 (pp. 19). Retrieved from https://www.webofscience.com/
2015
Alhamdi, Y., Abrams, S. T., Cheng, Z., Jing, S., Su, D., Liu, Z., . . . Toh,, C. -H. (2015). Circulating histones are major mediators of cardiac injury in patients with sepsis. Critical Care Medicine, 43(10), 2094-2103. doi:10.1097/CCM.0000000000001162DOI: 10.1097/CCM.0000000000001162
Undated
Su, D. (n.d.). Production, Characterisation and Application of Humanised Anti-Histone Antibodies in Critical Illness. (PhD Thesis, University of Liverpool).
